Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Shi, Hai ^a   Zhou, Yi ^b   Liu, Heliang ^a   Chen, Changsheng ^c   Li, Shujun ^a   Li, Nanlin ^a   Li, Xiaohua ^a   Zhang, Xi ^a   Zhang, Hongwei ^a   Wang, Weizhong ^a   Zhao, Qingchuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Tianjin Union Medicine Centre   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE INDUCED ANTI APOPTOTIC MOLECULE 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CIAPIN1 PROTEIN, HUMAN; MESSENGER RNA; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; UPREGULATION; WESTERN BLOTTING; ADJUVANT THERAPY; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RECTUM; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL DIFFERENTIATION; COLON; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77956470072     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-477     Document Type: Article

References (22)

1. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009, 361(25):2449-2460. 10.1056/NEJMra0804588, 2843693, 20018966.
2. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009, 59(6):366-378. 10.3322/caac.20038, 19897840.
3. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 2010, 11(1):50-54. 10.1111/j.1751-2980.2009.00413.x, 20132431.
4. Punt CJ, Tol J. More is less -- combining targeted therapies in metastatic colorectal cancer. Nat Rev Clin Oncol 2009, 6(12):731-733. 10.1038/nrclinonc.2009.168, 19942926.
5. Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 2010, 27(2):83-90. 10.1007/s10585-010-9305-4, 20143136.
6. Obeidat NA, Pradel FG, Zuckerman IH, DeLisle S, Mullins CD. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer. Am J Geriatr Pharmacother 2009, 7(6):343-354. 10.1016/j.amjopharm.2009.11.005, 20129255.
7. Ross JS. Biomarker update for breast, colorectal and non-small cell lung cancer. Drug News Perspect 2010, 23(1):82-88. 10.1358/dnp.2010.23.1.1437316, 20155222.
8. Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst 2009, 101(19):1308-1324. 10.1093/jnci/djp280, 2758310, 19738166.
9. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009, 9(7):489-499. 10.1038/nrc2645, 19536109.
10. Hammarström S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999, 9(2):67-81. 10.1006/scbi.1998.0119, 10202129.
11. Shibayama H, Takai E, Matsumura I, Kouno M, Morii E, Kitamura Y, Takeda J, Kanakura Y. Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis. J Exp Med 2004, 199(4):581-592. 10.1084/jem.20031858, 2211823, 14970183.
12. Hao Z, Li X, Qiao T, Du R, Zhang G, Fan D. Subcellular localization of CIAPIN1. J Histochem Cytochem 2006, 54(12):1437-1444. 10.1369/jhc.6A6960.2006, 16957168.
13. Hao Z, Li X, Qiao T, Zhang J, Shao X, Fan D. Distribution of CIAPIN1 in normal fetal and adult human tissues. J Histochem Cytochem 2006, 54(4):417-426. 10.1369/jhc.5A6753.2005, 16314443.
14. Li X, Hao Z, Fan R, Zou X, Jin H, Pan Y, He L, Du R, Gao L, Liu D, Fan D. CIAPIN1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating CyclinD1 and upregulating P27. Cancer Biol Ther 2007, 6(10):1539-1545. 10.4161/cbt.6.10.4684, 18293492.
15. Hao Z, Li X, Qiao T, Li S, Lv Y, Fan D. Downregulated expression of CIAPIN1 may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression. Cancer Biol Ther 2009, 8(11):1064-1070.
16. He L, Wang H, Jin H, Guo C, Xie H, Yan K, Li X, Shen Q, Qiao T, Chen G, Chai N, Zhao L, Dong Q, Zheng Y, Liu J, Fan D. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett 2009, 276(1):88-94. 10.1016/j.canlet.2008.10.044, 19081179.
17. Shi H, Chen S, Jin H, Xu C, Dong G, Zhao Q, Wang W, Zhang H, Lin W, Zhang J, Davidovic L, Yao L, Fan D. Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway. Cancer Sci 2009, 100(9):1585-1590. 10.1111/j.1349-7006.2009.01223.x, 19549253.
18. Shi H, Jin H, Chu D, Wang W, Zhang J, Chen C, Xu C, Fan D, Yao L. Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation. Biol Pharm Bull 2009, 32(6):968-975. 10.1248/bpb.32.968, 19483300.
19. Zhang J, Li F, Liu X, Shen L, Liu J, Su J, Zhang W, Deng Y, Wang L, Liu N, Han W, Zhang J, Ji S, Yang A, Han H, Yao L. The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J Biol Chem 2006, 281(51):39159-39168. 10.1074/jbc.M605820200, 17050536.
20. Yan K, He LJ, Cheng W, Ji ZZ, Zhao BX, Hui XL, Cao SS, Chen B, He L, Liang SH, Miao Y. Inhibiting gastric cancer-associated angiogenesis by CIAPIN1 siRNA. Cancer Biol Ther 2009, 8(11):1058-1063.
21. Li X, Pan Y, Fan R, Jin H, Han S, Liu J, Wu K, Fan D. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Carcinogenesis 2008, 29(8):1587-1593. 10.1093/carcin/bgn052, 2516489, 18299278.
22. Li X, Wu K, Fan D. CIAPIN1 as a therapeutic target in cancer. Expert Opin Ther Targets 2010, 14(6):603-610. 10.1517/14728221003774127, 20367238.